BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 21122392)

  • 1. [Diagnosis and treatment of occult breast cancer: report of 23 cases].
    Zhong Y; Sun Q; Huang HY; Zhou YD; Guan JH; Mao F; Lin Y; Xu YL
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):716-8. PubMed ID: 21122392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of occult breast cancer in 44 cases].
    Lu S; Liu H
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):550-2. PubMed ID: 22093638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
    Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
    Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
    McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
    Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of seven patients with occult breast cancer and literature reviews].
    Yu H; Yang MT; Rong TH; Long H; Ou W
    Ai Zheng; 2002 May; 21(5):541-3. PubMed ID: 12452050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
    Wang X; Zhao Y; Cao X
    Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis].
    Liao YQ; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):615-8. PubMed ID: 18210884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
    Yu J; Li G; Li J; Wang Y
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment patterns and affecting factors in breast cancer patients over 65-years of age].
    Mao Y; Chen X; Gao W; Liu J; Shen K
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):366-71. PubMed ID: 25030593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary nodal metastasis of occult breast primary cancer.
    Tamiolakis D; Antoniou C
    Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
    Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
    Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
    Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ
    Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.